403 related articles for article (PubMed ID: 30523244)
1. The emerging role of lncRNAs in inflammatory bowel disease.
Yarani R; Mirza AH; Kaur S; Pociot F
Exp Mol Med; 2018 Dec; 50(12):1-14. PubMed ID: 30523244
[TBL] [Abstract][Full Text] [Related]
2. The contribution of long non-coding RNAs in Inflammatory Bowel Diseases.
Zacharopoulou E; Gazouli M; Tzouvala M; Vezakis A; Karamanolis G
Dig Liver Dis; 2017 Oct; 49(10):1067-1072. PubMed ID: 28869157
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease.
Heydari R; Karimi P; Meyfour A
Biomed Pharmacother; 2024 Jul; 176():116868. PubMed ID: 38850647
[TBL] [Abstract][Full Text] [Related]
4. Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?
Lin L; Zhou G; Chen P; Wang Y; Han J; Chen M; He Y; Zhang S
Cell Death Dis; 2020 Jun; 11(6):456. PubMed ID: 32541691
[TBL] [Abstract][Full Text] [Related]
5. Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis.
Wu F; Huang Y; Dong F; Kwon JH
Inflamm Bowel Dis; 2016 Apr; 22(4):782-95. PubMed ID: 26937624
[TBL] [Abstract][Full Text] [Related]
6. A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.
Padua D; Mahurkar-Joshi S; Law IK; Polytarchou C; Vu JP; Pisegna JR; Shih D; Iliopoulos D; Pothoulakis C
Am J Physiol Gastrointest Liver Physiol; 2016 Sep; 311(3):G446-57. PubMed ID: 27492330
[TBL] [Abstract][Full Text] [Related]
7. "Decoding inflammation: glycoprotein a repetition predominant, microRNA-142-3-p, and metastasis associated lung adenocarcinoma transcript 1: as novel inflammatory biomarkers of inflammatory bowel disease".
Lahimchi MR; Mohammadnia-Afrouzi M; Baharlou R; Haghmorad D; Abedi SH; Arjmandi D; Hosseini M; Yousefi B
Mol Biol Rep; 2024 Apr; 51(1):500. PubMed ID: 38598005
[TBL] [Abstract][Full Text] [Related]
8. LncRNA: A Potential Research Direction in Intestinal Barrier Function.
Jiang ZF; Zhang L
Dig Dis Sci; 2021 May; 66(5):1400-1408. PubMed ID: 32591966
[TBL] [Abstract][Full Text] [Related]
9. Lnc-ing RNA to intestinal homeostasis and inflammation.
Fitzgerald KA; Shmuel-Galia L
Trends Immunol; 2024 Feb; 45(2):127-137. PubMed ID: 38220553
[TBL] [Abstract][Full Text] [Related]
10. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease.
Uhlig HH
Gut; 2013 Dec; 62(12):1795-805. PubMed ID: 24203055
[TBL] [Abstract][Full Text] [Related]
11. Role of long non-coding RNA in inflammatory bowel disease.
Hu Y; Lu Y; Fang Y; Zhang Q; Zheng Z; Zheng X; Ye X; Chen Y; Ding J; Yang J
Front Immunol; 2024; 15():1406538. PubMed ID: 38895124
[TBL] [Abstract][Full Text] [Related]
12. In Inflamed Intestinal Tissues and Epithelial Cells, Interleukin 22 Signaling Increases Expression of H19 Long Noncoding RNA, Which Promotes Mucosal Regeneration.
Geng H; Bu HF; Liu F; Wu L; Pfeifer K; Chou PM; Wang X; Sun J; Lu L; Pandey A; Bartolomei MS; De Plaen IG; Wang P; Yu J; Qian J; Tan XD
Gastroenterology; 2018 Jul; 155(1):144-155. PubMed ID: 29621481
[TBL] [Abstract][Full Text] [Related]
13. The crucial role of non-coding RNAs in the pathophysiology of inflammatory bowel disease.
Ghafouri-Fard S; Eghtedarian R; Taheri M
Biomed Pharmacother; 2020 Sep; 129():110507. PubMed ID: 32768980
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic landscape of lncRNAs in inflammatory bowel disease.
Mirza AH; Berthelsen CH; Seemann SE; Pan X; Frederiksen KS; Vilien M; Gorodkin J; Pociot F
Genome Med; 2015; 7(1):39. PubMed ID: 25991924
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of lncRNAs in the normal and diseased intestinal barrier.
Chen J; Wan J; Ye J; Xia L; Lu N
Inflamm Res; 2018 Sep; 67(9):757-764. PubMed ID: 30008030
[TBL] [Abstract][Full Text] [Related]
16. Innate and adaptive immunity in inflammatory bowel disease.
Geremia A; Biancheri P; Allan P; Corazza GR; Di Sabatino A
Autoimmun Rev; 2014 Jan; 13(1):3-10. PubMed ID: 23774107
[TBL] [Abstract][Full Text] [Related]
17. KIF9‑AS1, LINC01272 and DIO3OS lncRNAs as novel biomarkers for inflammatory bowel disease.
Wang S; Hou Y; Chen W; Wang J; Xie W; Zhang X; Zeng L
Mol Med Rep; 2018 Feb; 17(2):2195-2202. PubMed ID: 29207070
[TBL] [Abstract][Full Text] [Related]
18. News from the "5th International Meeting on Inflammatory Bowel Diseases" CAPRI 2010.
Latella G; Fiocchi C; Caprili R
J Crohns Colitis; 2010 Dec; 4(6):690-702. PubMed ID: 21122584
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis as a therapeutic paradigm in inflammatory bowel diseases.
Verstege MI; te Velde AA; Hommes DW
Acta Gastroenterol Belg; 2006; 69(4):406-12. PubMed ID: 17343084
[TBL] [Abstract][Full Text] [Related]
20. Effects of GWAS-associated genetic variants on lncRNAs within IBD and T1D candidate loci.
Mirza AH; Kaur S; Brorsson CA; Pociot F
PLoS One; 2014; 9(8):e105723. PubMed ID: 25144376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
